Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
New

SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

for
Locally Advanced /Metastatic Solid Tumors,
Location: Orlando FL, Sarasota FL, Nashville TN, Dallas TX
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07857616

Phase 1, Recruiting
New

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07542704

Phase 1, Recruiting
New

A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer

for
Advanced Solid Tumour
Location: Sarasota FL, Nashville TN
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07851103

Phase 1, Recruiting
New

Facial Expression Awareness Training to Understand and Recognize Emotions

for
Survivors of Pediatric Brain Tumors, Pediatric Cancer
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 6 - 13

Code: NCT07923370

Recruiting
New

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07737314

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis

for
Malignant Melanoma of Skin,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07890415

Phase 3, Recruiting

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

for
Brain Metastases, Cancer (With CNS Involvement)
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07227610

Phase 2, Recruiting

DOAC - Dosing Options in AntiCoagulation Prophylaxis

for
Cancer, VTE (Venous Thromboembolism)
Location: Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT07005024

Phase 3, Recruiting

Decoupling Immunotherapy Toxicity and Cancer Response

for
Tumor, Cardiovascular
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07382752

Recruiting

Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies

for
SMARCB1-Deficient Malignancies, Epithelioid Sarcoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT06444880

Phase 2, Recruiting

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Philadelphia PA, Columbus OH,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase 1, Recruiting

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Durham NC,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06635785

Phase 1, Phase 2, Recruiting

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

for
Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndromes,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05745285

Recruiting

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

for
Heart Failure, Cardiotoxicity, Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18 - 45

Code: NCT05023785

Recruiting

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

for
Refractory TdT-Positive Leukemia
Location: Boston MA, San Antonio TX
Sponsor: OncoVista, Inc.

Sex: All

Age: 18+

Code: NCT00709215

Phase 1, Phase 2, Recruiting

Diamond Blackfan Anemia Registry (DBAR)

for
Anemia, Blood Disease
Location: New Hyde Park NY
Sponsor: Northwell Health

Sex: All

Age: 0+

Code: NCT00106015

Recruiting

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

for
Leukemia, High Risk Acute Lymphoblastic Leukemia,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 25

Code: NCT06839456

Phase 1, Phase 2, Recruiting

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

for
B-NHL, B-Non Hodgkin Lymphoma, Acute Lymphocytic Leukemia,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 39

Code: NCT05442515

Phase 1, Phase 2, Recruiting

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for
Solid Tumors
Location: New Haven CT, Hackensack NJ, Los Angeles CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05471856

Phase 1, Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

for
Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer,
Location: Miami FL, Pittsburgh PA, Houston TX, Dallas TX,
Sponsor: KaliVir Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06444815

Phase 1, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial